← All trials
NCT06898723
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 1, 2024
- Primary completion
- Sep 30, 2026
- Completion date
- Sep 30, 2026
- First posted
- Mar 27, 2025
- Last posted
- Mar 27, 2025
- Enrollment
- 440
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Wannan Medical CollegeLead sponsor
- The Third People's Hospital of BengbuCollaborator
- Anhui Medical UniversityCollaborator
- Anhui Medical UniversityCollaborator
- Anhui Medical UniversityCollaborator
- Soochow UniversityCollaborator
- Xuancheng people's hospitalCollaborator
- Tongling People's HospitalCollaborator
- Wuhu City Second People's HospitalCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.